Diagnostic performance of APRI, FIB-4, and shear wave elastography for liver fibrosis assessment in children with chronic liver disease: impact of necroinflammatory activity in an autoimmune hepatitis–dominated cohort

Background Liver fibrosis staging is central to managing children with chronic liver disease (CLD). Serum indices and shear wave elastography (SWE) offer non-invasive assessment, but pediatric validation remains limited. We evaluated the aspartate aminotransferase-to-platelet ratio index (APRI), fibrosis-4 (FIB-4), and two-dimensional SWE against biopsy fibrosis stage and explored associations with activity. Methods This prospective cross-sectional study included 45 children aged 6–18 years with CLD; eight of 53 recruited children could not complete SWE. Biopsy reports were retrieved from records. Continuous-marker diagnostic accuracy and exploratory numerical SWE-category agreement were evaluated. Results Autoimmune hepatitis (AIH) accounted for 27/45 (60%); all had recorded immunosuppression. Biopsy stages were F1 in 11, F2 in eight, F3 in 22, and F4 in four patients. APRI, FIB-4, and SWE correlated with fibrosis stage (Spearman rho 0.72, 0.68, 0.77; all p < 0.001). Areas under the receiver operating characteristic curve for significant fibrosis (≥F2) were 0.91, 0.85, and 0.92, and for cirrhosis were 0.88, 0.90, and 0.83, respectively. Exploratory SWE categories were concordant with biopsy in 40%, higher in 40%, and lower in 20% (weighted kappa 0.753). Median AST in higher-category, concordant and lower-category groups was 78.5, 56.0 and 33.0 U/L (overall p = 0.010). Observed cirrhosis negative predictive values were 100%, but estimates were based on four F4 cases. Conclusion The markers were associated with fibrosis stage, but cohort-derived thresholds and cirrhosis estimates require independent validation. Higher transaminases accompanied higher numerical SWE categories relative to biopsy; non-pediatric thresholds, temporal uncertainty, and biopsy sampling limitations preclude attributing discordance independently to inflammation.

Authors

Institutions

Publication Details

Journal
Frontiers in Pediatrics
Published
2026-11-17
DOI
https://doi.org/10.3389/fped.2026.1974671
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic performance of APRI, FIB-4, and shear wave elastography for liver fibrosis assessment in children with chronic liver disease: impact of necroinflammatory activity in an autoimmune hepatitis–dominated cohort

Mohamed Saaed Eldin ElAdawy, Iman Mohamed Talaat, Kareem Ahmed Abdelaziz Sabry, Ahmed Fouad Abdelwanees Abdalla
1 links
Frontiers in Pediatrics
Liver Disease Diagnosis and Treatment
article

Diagnostic performance of APRI, FIB-4, and shear wave elastography for liver fibrosis assessment in children with chronic liver disease: impact of necroinflammatory activity in an autoimmune hepatitis–dominated cohort

Mohamed Saaed Eldin ElAdawy, Iman Mohamed Talaat, Kareem Ahmed Abdelaziz Sabry, Ahmed Fouad Abdelwanees Abdalla
article en

Abstract

Background Liver fibrosis staging is central to managing children with chronic liver disease (CLD). Serum indices and shear wave elastography (SWE) offer non-invasive assessment, but pediatric validation remains limited. We evaluated the aspartate aminotransferase-to-platelet ratio index (APRI), fibrosis-4 (FIB-4), and two-dimensional SWE against biopsy fibrosis stage and explored associations with activity. Methods This prospective cross-sectional study included 45 children aged 6–18 years with CLD; eight of 53 recruited children could not complete SWE. Biopsy reports were retrieved from records. Continuous-marker diagnostic accuracy and exploratory numerical SWE-category agreement were evaluated. Results Autoimmune hepatitis (AIH) accounted for 27/45 (60%); all had recorded immunosuppression. Biopsy stages were F1 in 11, F2 in eight, F3 in 22, and F4 in four patients. APRI, FIB-4, and SWE correlated with fibrosis stage (Spearman rho 0.72, 0.68, 0.77; all p < 0.001). Areas under the receiver operating characteristic curve for significant fibrosis (≥F2) were 0.91, 0.85, and 0.92, and for cirrhosis were 0.88, 0.90, and 0.83, respectively. Exploratory SWE categories were concordant with biopsy in 40%, higher in 40%, and lower in 20% (weighted kappa 0.753). Median AST in higher-category, concordant and lower-category groups was 78.5, 56.0 and 33.0 U/L (overall p = 0.010). Observed cirrhosis negative predictive values were 100%, but estimates were based on four F4 cases. Conclusion The markers were associated with fibrosis stage, but cohort-derived thresholds and cirrhosis estimates require independent validation. Higher transaminases accompanied higher numerical SWE categories relative to biopsy; non-pediatric thresholds, temporal uncertainty, and biopsy sampling limitations preclude attributing discordance independently to inflammation.

Frontiers in PediatricsVol. 14
Ain Shams University (EG), Ain Shams University Hospital (EG), Ministry of Health and Population (EG)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon